ArticleJournal of translational medicine2025

Impacts of genomic alterations on the efficacy of HER2-targeted antibody-drug conjugates in patients with metastatic breast cancer.

Riqing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.